Clinical Trials Browser

Phase 3 × Has results × Thyroid Neoplasms × Clear all

NCT03690388 2025-09-25

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Phase 3 Active not recruiting

187 enrolled 13 charts 1 FDA

EndocrineHead & Neck

Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT00410761 2025-09-24

An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

Phase 3 Completed

331 enrolled 15 charts

EndocrineHead & Neck

Familial medullary thyroid carcinoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT01321554 2023-06-22

SELECT

Phase 3 Completed

392 enrolled 10 charts

Thyroid Neoplasms

NCT00704730 2021-04-20

EXAM

Phase 3 Completed

330 enrolled 14 charts

Thyroid Neoplasms, Carcinoma, Medullary

NCT00984282 2018-09-13

Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Phase 3 Completed

417 enrolled 22 charts

Thyroid Neoplasms

NCT02112370 2017-08-04

REBT

Phase 3 Completed

148 enrolled 17 charts

Goiter, Thyroid Neoplasms

NCT01126060 2011-12-19

Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain

Phase 3 Completed

78 enrolled 6 charts

Thyroid Neoplasms